BIONET Corp. (1784.TWO)

TWD 76.9

(-9.95%)

Long Term Debt Summary of BIONET Corp.

  • BIONET Corp.'s latest annual long term debt in 2023 was 6.03 Million TWD , down -0.87% from previous year.
  • BIONET Corp.'s latest quarterly long term debt in 2024 Q2 was 24.02 Million TWD , down 0.0% from previous quarter.
  • BIONET Corp. reported annual long term debt of 6.08 Million TWD in 2022, down -22.23% from previous year.
  • BIONET Corp. reported annual long term debt of 7.82 Million TWD in 2021, up 15.22% from previous year.
  • BIONET Corp. reported quarterly long term debt of 24.02 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • BIONET Corp. reported quarterly long term debt of 6.03 Million TWD for 2023 Q4, up 17.16% from previous quarter.

Annual Long Term Debt Chart of BIONET Corp. (2023 - 2019)

Historical Annual Long Term Debt of BIONET Corp. (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 6.03 Million TWD -0.87%
2022 6.08 Million TWD -22.23%
2021 7.82 Million TWD 15.22%
2020 6.79 Million TWD 102.83%
2019 -240.1 Million TWD 0.0%

Peer Long Term Debt Comparison of BIONET Corp.

Name Long Term Debt Long Term Debt Difference
DIVA Laboratories, Ltd. - TWD -Infinity%
Genetics Generation Advancement Corp. 10.34 Million TWD 41.653%
Welgene Biotech Co.,Ltd. 118.97 Million TWD 94.926%
Puriblood Medical Co., Ltd. 43.7 Million TWD 86.188%
TFBS Bioscience Inc. 101.84 Million TWD 94.073%